Eli Lilly (LLY)

• Market cap: $760B
• 1 day: 4.19%
• 5 days: 3.97%
• 1 month: 11.09%
• 3 months: 11.52%
• 6 months: -5.71%
• Year to date: 8.94%
• 1 year: 0.09%
• 5 years: 549.71%
• 10 years: 939.12%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 47,000